0 items USD 0.00Search
Your search for "globaldata chronic myelocytic leukemia cml chronic myeloid leukemia global clinical trials review h1" gave back 763237 results.
The global Ponatinib HCl market size was valued at US$ million in 2022. With growing demand in downstream market and recovery from influence of COVID...
Catalog:
LPI
August 2023
Price: USD 3,660.00
The global Adult T-Cell Leukemia/Lymphoma Treatment market size was valued at US$ 120.9 million in 2023. With growing demand in downstream market,...
Catalog:
LPI
January 2024
Price: USD 3,660.00
The global Azacitidine Injection market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %...
Catalog:
MRRPB5
March 2024
Price: USD 2,900.00
Imatinib is a chemotherapy drug that acts by reducing or preventing the progression of cancer cells. This drug is used for the treatment of certain...
Catalog:
MRRPB5
October 2023
Price: USD 2,900.00
Bcr-Abl Antibody is a specific antibody used to detect and study Bcr-Abl protein. The global Bcr-Abl Antibody market is projected to reach US$ 894.4...
Catalog:
MRRPB5
October 2023
Price: USD 2,900.00
Dasatinib, sold under the brand name Sprycel, is a chemotherapy medication used to treat certain cases of chronic myelogenous leukemia (CML) and...
Catalog:
MRRPB5
November 2023
Price: USD 3,350.00
Adult T-cell lymphoma/leukemia (ATL) is a rare T-cell lymphoproliferative neoplasm caused by human T-lymphotrophic virus 1. In its more common,...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
Treatment options for chronic lymphocytic leukemia (CLL) vary greatly, depending on the person’s age, the disease risk group, and the reason for...
Catalog:
MRRPB5
February 2024
Price: USD 2,900.00
Treatment options for chronic lymphocytic leukemia (CLL) vary greatly, depending on the person’s age, the disease risk group, and the reason for...
Catalog:
MRRPB5
October 2023
Price: USD 2,900.00
The global Azacitidine Injection market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR...
Catalog:
MRRPB5
July 2023
Price: USD 4,900.00
Acute myeloid leukemia (AML) is a type of blood cancer. Learn more about AML causes, symptoms, diagnosis, and treatment. Market Analysis and Insights...
Catalog:
MRRPB5
June 2023
Price: USD 4,900.00
Market Analysis and Insights: Global Acute Myeloid Leukemia (AML) Biomarker Testing Market The global Acute Myeloid Leukemia (AML) Biomarker Testing...
Catalog:
MRRPB5
September 2023
Price: USD 4,900.00
The global Pharmerging market size was valued at US$ 888 million in 2023. With growing demand in downstream market, the Pharmerging is forecast to a...
Catalog:
LPI
February 2024
Price: USD 3,660.00
Acute myeloid leukemia (AML) is a type of blood cancer. Learn more about AML causes, symptoms, diagnosis, and treatment. Highlights The global Acute...
Catalog:
MRRPB5
May 2023
Price: USD 2,900.00
TASIGNA can be prescribed to treat Philadelphia chromosome-positive chronic myeloid leukemia. The global Tasigna market is projected to reach US$...
Catalog:
MRRPB5
September 2023
Price: USD 2,900.00
